Table 1.
Sample | Clinical diagnosis | Tissue-type obtained | Age | Major axis of tumor (cm) | Preoperative therapy |
---|---|---|---|---|---|
NM1 | Cervical cancer, stage Ib1 | Normal myometrium | 43 | — | None |
NM2 | Cervical cancer, stage Ib2 | Normal myometrium | 38 | — | None |
NM3 | Cervical cancer, stage Ib2 | Normal myometrium | 49 | — | None |
LM1 | Interstitial myoma | Leiomyoma | 52 | 18 | None |
LM2 | Submucosal myoma | Leiomyoma | 48 | 6 | None |
LM3 | Submucosal myoma | Leiomyoma | 53 | 6 | GnRHa |
LMS1 | Leiomyosarcoma, stage IV | Leiomyosarcoma | 49 | 25 | None |
LMS2 | Leiomyosarcoma, stage I | Leiomyosarcoma | 54 | 20 | None |
LMS3 | Leiomyosarcoma, stage I | Leiomyosarcoma | 83 | 10 | None |
GnRHa, gonadotrophin-releasing hormone analogues.